IARC
VerifiedResearch Company/Group
The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization. The objective of IARC is to promote international collaboration in cancer research. The Center is interdisciplinary, and brings together skills in laboratory disciplines, epidemiology and biostatistics to identify the causes of cancer, which will allow the adoption of preventive measures to reduce the burden and suffering associated with the disease. An important feature of IARC is its expertise in coordinating research between different countries and different organizations: its independent role as an international organization facilitates this activity. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | France |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesAtlas of breast cancer early detection
Go back to the list of case studies Click on the pictures to magnify and display the legends Case number: 177 Age: 39 Clinical presentation: Premenopausal woman with average risk of developing breast cancer presented with a left breast areolar nodule. On examination, there was expressible serous discharge from the left nipple.
Guía del Usuario TNM Esencial
TNM Esencial, un sistema de estadificación simplificado para los registros de cáncer es un complemento de la clasificación completa Tumor, Nódulo, Metástasis (TNM), para asignar el estadio del cáncer en el momento del diagnóstico. TNM Esencial es para uso de los registradores de cáncer cuando el grupo de estadio TNM tradicional (o completo) (I, II, III o IV) o sus componentes TNM (T, N y M) no se han registrado explícitamente en el expediente médico del paciente.
Learning Centre - Cancer Prevention
The Cancer Prevention Europe (CPE) Learning Centre will provide certified and non-certified learning modules and other materials (i.e. webinars, knowledge clips, and podcasts) on cancer prevention, to build capacity and support knowledge transfer.
Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation
As part of the Accelerating Gastric Cancer Reduction in Europe through Helicobacter pylori Eradication (EUROHELICAN) project, the International Agency for Research on Cancer (IARC) convened a Working Group of international, interdisciplinary experts in February 2025 to discuss best practices in the implementation of population-based H. pylori screen-and-treat strategies for adult populations for gastric cancer prevention.
Endocrine and Neuroendocrine Tumours
The WHO Classification of Tumours Endocrine and Neuroendocrine Tumours is Volume 10 in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology.
The global initiative for cancer registry development
As part of the Global Initiative for Cancer Registry Development programme (GICR), led by the International Agency for Cancer Research (IARC), the GICR e-Learning (eGICR) Series aims to create a new legacy of learners by offering free, self-paced education and training in cancer surveillance. Who is the eGICR series for ? What is included in the eGICR series ? What do I get for completing ? Partners Prior experience in cancer registry operations is not required to take this e-learning series.
WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology
The IAC-IARC-WHO Cytopathology Reporting Systems The WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology is Volume 3 of this new series of reporting systems for cytopathology, which is a joint project of the International Academy of Cytology (IAC) and the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization (WHO).
User’s Guide to Essential TNM
Essential TNM, a simplified staging system for cancer registries, is a complement to the full Tumour, Node, Metastasis (TNM) classification, to assign cancer stage at diagnosis. It is for use by cancer registrars when either the traditional (or full) TNM stage group (I, II, III, or IV) or the TNM staging components (T, N, and M) have not been explicitly recorded in the patient’s record.
Cancer Incidence in Five Continents Volume XII
IARC Scientific Publication No. 169 Edited by Bray F, Colombet M, Aitken JF, Bardot A, Eser S, Galceran J, Hagenimana M, Matsuda T, Mery L, Piñeros M, Soerjomataram I, de Vries E, Wiggins C, Won YJ, Znaor A and Ferlay J 2024 ISBN-13 978-92-832-2224-8